TC Biopharm ()
(TCBP)
undefined
undefined%
At close: undefined
0.52
0.85%
After-hours Dec 13, 2024, 07:40 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Revenue | - | 3.84M | 1.98M | 1.98M | 3.43M |
Cost of Revenue | - | - | - | - | - |
Gross Profit | - | 3.84M | 1.98M | 1.98M | 3.43M |
Operating Income | -14.24M | -12.08M | -7.29M | -6.89M | -6.64M |
Interest Income | 83.03K | 6.75M | 3.44M | 291.03K | 253.51K |
Pretax Income | -7.00M | -3.03M | -14.98M | -6.63M | -6.89M |
Net Income | -5.91M | -1.31M | -13.58M | -5.46M | -6.07M |
Selling & General & Admin | 6.87M | 8.74M | 3.11M | 2.21M | 3.01M |
Research & Development | 7.77M | 7.59M | 6.16M | 6.68M | 8.61M |
Other Expenses | - | - | - | - | - |
Operating Expenses | 6.91M | 124.90K | 13.52M | 8.32M | 10.07M |
Interest Expense | - | 6.75M | 3.44M | 292.06K | 275.41K |
Selling & Marketing Expenses | 402.31K | 402.31K | - | - | - |
Cost & Expenses | 6.91M | 124.90K | 13.52M | 8.32M | 10.07M |
Income Tax | -1.09M | 1.72M | 1.41M | 1.17M | 826.07K |
Shares Outstanding (Basic) | 30.89K | 3.44K | 1.95K | 1.89K | 1.89K |
Shares Outstanding (Diluted) | 30.89K | 3.44K | 1.95K | 1.89K | 1.89K |
EPS (Basic) | -191.21 | -382.31 | -6.95K | -2.88K | - |
EPS (Diluted) | -191.21 | -382.31 | -6.95K | -2.88K | - |
EBITDA | -13.61M | -11.32M | -6.48M | -5.26M | -5.92M |
Depreciation & Amortization | 630.06K | 762.47K | 811.96K | 878.64K | 721.93K |